GeeFi (GEE) Celebrates Presale’s Milestones by Announcing New Giveaway to Its Community
KINGSTOWN, St. Vincent and the Grenadines, Dec. 19, 2025 (GLOBE NEWSWIRE) — Anticipation is building rapidly within the GeeFi ecosystem…
Major shareholder announcement
Pursuant to Section 30 of the Danish Capital Markets Act, ALK (ALKB:DC / OMX: ALK B) hereby announces that Arbejdsmarkedets…
Did James Altucher Call the Starlink IPO Years Early?
Most Recent Video Revisits His 2026 Prediction as Starlink’s Growth Accelerates Washington, D.C., Dec. 19, 2025 (GLOBE NEWSWIRE) — Wall…
MGC’s Next Evolution: From Gaming Token to a Trusted Asset for Cross-Platform Web3 Partnerships
DUBAI, United Arab Emirates, Dec. 19, 2025 (GLOBE NEWSWIRE) — As Web3 gaming and decentralized applications mature, platforms are no…
CCSC Technology International Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG, Dec. 19, 2025 (GLOBE NEWSWIRE) — CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a…
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Reducing inflammation helps create a regenerative environment in the Central Nervous System TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE…
Vine Hill Capital Investment Corp. II Announces Closing of Upsized $230 Million Initial Public Offering
Fort Lauderdale, Florida, Dec. 19, 2025 (GLOBE NEWSWIRE) — Vine Hill Capital Investment Corp. II (the “Company”), a special purpose…
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM…
GeeFi (GEE) Shows Resilience Amid Market Pressure as Its Presale Nears $1.5M Raised in a Few Weeks
KINGSTOWN, St. Vincent and Grenadines, Dec. 19, 2025 (GLOBE NEWSWIRE) — Amidst a period of significant fluctuation in the broader…
JHX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important December 23 Deadline in Securities Class Action – JHX
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers…
Silly Nice Welcomes Schedule III—But Says Justice Reform Must Follow
Black & Veteran-owned cannabis brand applauds federal reform while calling for expungement and equity-focused next steps New York, New York,…
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
↑